These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19160444)

  • 41. Stenting of the unprotected left main coronary artery in patients with severe aortic stenosis prior to percutaneous valve interventions.
    Jaffe R; Finkelstein A; Lewis BS; Guetta V; Khader N; Rubinshtein R; Halon DA; Segev A
    Cardiovasc Revasc Med; 2012; 13(2):90-4. PubMed ID: 22296780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis.
    Rodés-Cabau J; Dumont E; De LaRochellière R; Doyle D; Lemieux J; Bergeron S; Clavel MA; Villeneuve J; Raby K; Bertrand OF; Pibarot P
    Am J Cardiol; 2008 Nov; 102(9):1240-6. PubMed ID: 18940300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of concomitant percutaneous coronary intervention and balloon aortic valvuloplasty.
    Ben-Dor I; Maluenda G; Looser PM; Okubagzi P; Torguson R; Xue Z; Lindsay J; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E835-41. PubMed ID: 21735514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary angioplasty after self-expandable transcatheter aortic valve implantation.
    Greenberg G; Kornowski R
    J Invasive Cardiol; 2013 Jul; 25(7):361-3. PubMed ID: 23813067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concomitant coronary intervention is associated with poorer early and late clinical outcomes in selected elderly patients receiving transcatheter aortic valve implantation.
    Griese DP; Reents W; Tóth A; Kerber S; Diegeler A; Babin-Ebell J
    Eur J Cardiothorac Surg; 2014 Jul; 46(1):e1-7. PubMed ID: 24819362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic support using the Impella 2.5 catheter system during high-risk percutaneous coronary intervention in a patient with severe aortic stenosis.
    Harjai KJ; O'Neill WW
    J Interv Cardiol; 2010 Feb; 23(1):66-9. PubMed ID: 20040004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Minimally Invasive Mitral Valve Replacement and Transfemoral Aortic Valve Implantation.
    Rustenbach C; Baumbach H; Hill S; Franke UF
    J Heart Valve Dis; 2015 Jan; 24(1):43-5. PubMed ID: 26182618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of a percutaneous ventricular assist device for treatment of cardiogenic shock due to critical aortic stenosis.
    Frank CM; Palanichamy N; Kar B; Wilson JM; Gregoric ID; Loyalka P; Civitello AB
    Tex Heart Inst J; 2006; 33(4):487-9. PubMed ID: 17215976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis.
    Buellesfeld L; Gerckens U; Grube E
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):579-84. PubMed ID: 18360844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication.
    Gerckens U; Latsios G; Mueller R; Buellesfeld L; Sauren B; Iversen S; Felderhof T; Grube E
    Clin Res Cardiol; 2009 Oct; 98(10):687-90. PubMed ID: 19688178
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
    O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
    JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful use of a left ventricular apical access and closure device for second-generation transapical aortic valve implantation.
    Conradi L; Seiffert M; Shimamura K; Schirmer J; Blankenberg S; Reichenspurner H; Diemert P; Treede H
    Thorac Cardiovasc Surg; 2014 Sep; 62(6):498-502. PubMed ID: 24911901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J; Lee MS; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.
    Grube E; Laborde JC; Gerckens U; Felderhoff T; Sauren B; Buellesfeld L; Mueller R; Menichelli M; Schmidt T; Zickmann B; Iversen S; Stone GW
    Circulation; 2006 Oct; 114(15):1616-24. PubMed ID: 17015786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcatheter aortic valve-in-valve implantation of a CoreValve in a degenerated aortic bioprosthesis.
    Bruschi G; DeMarco F; Oreglia J; Colombo P; Fratto P; Lullo F; Paino R; Martinelli L; Klugmann S
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):182-5. PubMed ID: 19829135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation.
    Napodano M; Gasparetto V; Tarantini G; Fraccaro C; Yzeiraj E; Gerosa G; Isabella G; Iliceto S
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):996-1003. PubMed ID: 22114036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study.
    Clavel MA; Fuchs C; Burwash IG; Mundigler G; Dumesnil JG; Baumgartner H; Bergler-Klein J; Beanlands RS; Mathieu P; Magne J; Pibarot P
    Circulation; 2008 Sep; 118(14 Suppl):S234-42. PubMed ID: 18824760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.